ev3

ev3, now a part of Medtronic, has been an established entity in the Biotechnology and Health Care industries since its founding in 1960. This acquisition underscores Medtronic's commitment to enhancing its portfolio in medical technologies and treatments.

Headquartered in the United States, ev3's strategic integration into Medtronic suggests a promising expansion of capabilities and resources, catering to a broader market need for innovation in health solutions.

The company's last reported investment was a substantial $34.65 million Post-IPO Equity on 09 June 2009. Though specific investors were not disclosed, this funding round signals confidence in the scalability and potential of ev3's technologies under the Medtronic umbrella.

For investors, evaluating the synergies between ev3 and Medtronic could reveal opportunities for growth, especially in harnessing advanced medical treatments and technologies in the ever-evolving healthcare landscape.